Enzyme, powered by the MLN token, is a digital asset management platform that strives to streamline the management of digital assets. It provides a unified, user-friendly on-chain system that allows access to digital assets and DeFi from a single application. Enzyme aims to eliminate operational risks associated with managing crypto and DeFi assets without purpose-built smart-contract permissions and controls. It provides a robust suite of programmable risk management and governance tools to protect assets. Enzyme also maintains sophisticated on-chain data pipelines, ensuring data is auditable and trustworthy, promoting a future based on transparency and auditability.

Enzyme operates through a system of vaults, each representing a unique portfolio with its own strategy, asset allocation, and investment goals. Users can create multiple vaults and customize each one according to their preferences. Enzyme provides tools for managing and monitoring these portfolios, including performance metrics and detailed reporting. This makes it easy for users to track the performance of their assets and make informed decisions about how to manage their portfolios over time. Enzyme also provides real-time reporting and performance dashboards with key performance and risk metrics, and reports that provide easily readable and provable data on all transactions at any point in history.

Enzyme has a wide range of potential use cases. For instance, it can be used for treasury management, allowing organizations to manage their treasury simply, securely, and transparently. It can also be used to set up an on-chain DeFi fund, with Enzyme taking care of all fund operations and administration using smart-contract automation. Additionally, users can build their own indexes in minutes and have them rebalance automatically on-chain or off-chain. Enzyme also allows anyone to build, scale, and monetize investment strategies using the protocol's non-custodial Vaults. These strategies can span the spectrum from traditional discretionary allocators to DeFi-native combinations of any of the primitives with which Enzyme integrates.

Enzyme, formerly known as the Melon Protocol, was initially developed by the private company Melonport. After the dissolution of Melonport, the protocol was transferred to the Enzyme Council. The protocol has been on the mainnet since February 2019 and was the first DeFi protocol to decentralize its governance. Enzyme v2, a completely re-architected protocol with modularity and extensibility at the core of its design, was launched to the mainnet in January 2021. The Enzyme token, MLN, is used to access the MLN network and incentivize developers to build on Enzyme.

我们实时将 Enzyme 更新为 USD 货币。通过 Coinbase 获取最新 Enzyme 价格。

Enzyme的当前市值为 US$369.689万。高市值意味着该资产在市场上的价值很高。

Enzyme的历史最高价位是 US$270.05。这是Enzyme自推出以来的最高价格。

在过去 24 小时内，Enzyme的交易量为 US$7.937万。

与Enzyme具有相似市值的资产包括Bitmine Tokenised Stock (xStock), Pfizer Tokenized Stock (Ondo), Lumentum Tokenized bStocks和许多其他资产。要查看完整列表，请参阅我们的可比市值资产。

Enzyme的当前流通供应量是 327万。

Enzyme在 Coinbase 上的可交易资产中排名 220。受欢迎程度目前基于相对市值。

目前，有 63% 的 Coinbase 用户正在购买Enzyme。换句话说，63% 的 Coinbase 客户在过去 24 小时内通过交易增加了他们在Enzyme的净头寸。